U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Product Details

Additional Information about Patents

  • Patent information is published on or after the submission date as defined in 21 CFR 314.53(d)(5).
  • Patent listings published prior to August 18, 2003, only identify method-of-use claims. The listed patents may include drug substance and/or drug product claims that are not indicated in the listing.
  • As of December 5, 2016, an NDA holder submitting information on a patent that claims both the drug substance and the drug product (and is eligible for listing on either basis) is required only to specify that it claims either the drug substance or the drug product. Orange Book users should not rely on an Orange Book patent listing, regardless of when first published, to determine the range of patent claims that may be asserted by an NDA holder or patent owner.

Patent and Exclusivity for: N210563

Product 001
IBRUTINIB (IMBRUVICA) TABLET 140MG

Patent Data

Product No Patent No Patent Expiration Drug Substance Drug Product Patent Use Code Delist Requested Submission Date
001 7514444 12/28/2026 DS DP 03/06/2018
001 7514444*PED 06/28/2027
001 8008309 11/13/2027 DS DP 03/06/2018
001 8008309*PED 05/13/2028
001 8476284 12/28/2026 U-1650 U-1946 U-2241 03/06/2018
001 8476284*PED 06/28/2027
001 8497277 12/28/2026 U-1491 U-1650 U-1946 U-2241 U-2242 U-3422 03/06/2018
001 8497277*PED 06/28/2027
001 8563563 04/26/2027 U-1491 U-1650 U-1946 U-2241 U-2242 03/06/2018
001 8563563*PED 10/26/2027
001 8697711 12/28/2026 DS DP 03/06/2018
001 8697711*PED 06/28/2027
001 8703780 12/28/2026 U-1491 U-2242 03/06/2018
001 8703780*PED 06/28/2027
001 8735403 12/28/2026 DS DP 03/06/2018
001 8735403*PED 06/28/2027
001 8754091 12/28/2026 DP 03/06/2018
001 8754091*PED 06/28/2027
001 8952015 12/28/2026 U-1491 U-1650 U-1946 U-2241 U-2242 03/06/2018
001 8952015*PED 06/28/2027
001 8957079 12/28/2026 DS DP 03/06/2018
001 8957079*PED 06/28/2027
001 8999999 06/03/2031 U-1491 U-1946 U-2241 U-2242 03/06/2018
001 8999999*PED 12/03/2031
001 9125889 06/03/2031 U-1650 03/06/2018
001 9125889*PED 12/03/2031
001 9181257 12/28/2026 DS 03/06/2018
001 9181257*PED 06/28/2027
001 9296753 10/30/2033 DS 03/06/2018
001 9296753*PED 04/30/2034
001 9655857 03/03/2036 DP 03/06/2018
001 9655857*PED 09/03/2036
001 9725455 06/03/2033 DS 03/06/2018
001 9725455*PED 12/03/2033
001 9795604 10/24/2034 U-2969 U-2970 U-3422 03/06/2018
001 9795604*PED 04/24/2035
001 9801881 06/03/2031 U-1491 U-2242 03/06/2018
001 9801881*PED 12/03/2031
001 9801883 06/03/2031 U-2159 U-2243 03/06/2018
001 9801883*PED 12/03/2031
001 10004746 06/03/2031 U-1684 U-1946 U-2241 U-2242 07/17/2018
001 10004746*PED 12/03/2031
001 10010507 03/03/2036 DP 07/17/2018
001 10010507*PED 09/03/2036
001 10016435 06/03/2031 U-1650 08/02/2018
001 10016435*PED 12/03/2031
001 10106548 06/03/2033 DS DP 10/26/2018
001 10106548*PED 12/03/2033
001 10125140 06/03/2033 DS DP 11/16/2018
001 10125140*PED 12/03/2033
001 10213386 03/03/2036 DP 03/08/2019
001 10213386*PED 09/03/2036
001 10463668 10/24/2034 U-2654 11/15/2019
001 10463668*PED 04/24/2035
001 10478439 06/03/2031 U-1650 U-1684 U-1946 U-2241 U-2242 U-2665 U-3422 12/10/2019
001 10478439*PED 12/03/2031
001 10695350 10/24/2034 U-2846 07/13/2020
001 10695350*PED 04/24/2035
001 10751342 06/03/2031 U-1491 U-1946 U-2943 U-2944 09/10/2020
001 10751342*PED 12/03/2031
001 10752634 06/03/2033 DP 09/10/2020
001 10752634*PED 12/03/2033
001 10828259 03/03/2036 DP 11/18/2020
001 10828259*PED 09/03/2036
001 10961251 06/03/2033 DP 04/16/2021
001 10961251*PED 12/03/2033
001 11672803 06/03/2031 U-1684 U-1946 U-2241 U-2242 07/14/2023
001 12551448 03/03/2036 DP 03/17/2026

Exclusivity Data

Product No Exclusivity Code Exclusivity Expiration
001 NPP 08/24/2025
001 NPP *PED 02/24/2026
001 ODE-405 08/24/2029
001 ODE-405 *PED 02/24/2030

 

 


View a list of all patent use codes
View a list of all exclusivity codes

Back to Top